FIGURE 8.
Schematic representation of the plausible mechanism of action for therapeutic effects of Cf-02 on ASLN. ASLN, accelerated, severe lupus nephritis; Cf-02, a novel benzamide-linked small molecule
Schematic representation of the plausible mechanism of action for therapeutic effects of Cf-02 on ASLN. ASLN, accelerated, severe lupus nephritis; Cf-02, a novel benzamide-linked small molecule